| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NSSC | Common Stock | Sale | -$81,500,000 | -2,000,000 | -53.97% | $40.75 | 1,706,010 | 08 Mar 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | NSSC | Employee Stock Option (Right to Buy) | 100,000 | 08 Mar 2024 | Common Stock | 100,000 | $22.5 | Direct | F2 | |||||
| holding | NSSC | Employee Stock Option (Right to Buy) | 10,000 | 08 Mar 2024 | Common Stock | 10,000 | $26.94 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | Pursuant to a Registration Statement on Form S-3 that became effective on March 5, 2024 and an underwriting agreement dated March 5, 2024, Mr. Soloway sold 2,000,000 shares of common stock of the Issuer in an underwritten secondary public offering. The shares were sold at a public offering price of $40.75 per share and Mr. Soloway paid an underwriting discount and commission of $1.01875 per share, resulting in a net price of $39.73125 per share. Mr. Soloway also granted the underwriters a 30-day option to purchase 300,000 additional shares of common stock at the same price and at the same underwriting discount and commission. |
| F2 | Exercisable, cumulatively, at 20% per year commencing October 19, 2021. |
| F3 | Exercisable, cumulatively, at 20% per year commencing August 25, 2022. |